Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aptorum Group Ltd Cl A (APM)

Aptorum Group Ltd Cl A (APM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,482
  • Shares Outstanding, K 5,182
  • Annual Sales, $ 430 K
  • Annual Income, $ -2,820 K
  • EBIT $ 0 M
  • EBITDA $ -10 M
  • 60-Month Beta 1.28
  • Price/Sales 8.82
  • Price/Cash Flow N/A
  • Price/Book 0.29
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/30/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6062 +41.88%
on 11/27/24
0.9600 -10.41%
on 12/26/24
+0.1899 (+28.33%)
since 11/26/24
3-Month
0.4600 +86.98%
on 11/18/24
2.0000 -56.99%
on 10/07/24
-1.0149 (-54.13%)
since 09/26/24
52-Week
0.4600 +86.98%
on 11/18/24
17.4900 -95.08%
on 03/06/24
-1.4699 (-63.09%)
since 12/26/23

Most Recent Stories

More News
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023

Regulatory News:

APM : 0.8601 (-0.55%)
Aptorum Group Announces 1-for-10 Reverse Stock Split

Regulatory News:

APM : 0.8601 (-0.55%)

Business Summary

Aptorum Group Limited is a pharmaceutical company. It engaged in developing and commercializing therapeutic and diagnostic technologies to tackle unmet medical needs. The company's therapeutic and diagnostic project primarily includes neurology, infectious diseases, gastroenterology, oncology and other...

See More

Key Turning Points

3rd Resistance Point 1.0331
2nd Resistance Point 0.9966
1st Resistance Point 0.9283
Last Price 0.8601
1st Support Level 0.8235
2nd Support Level 0.7870
3rd Support Level 0.7187

See More

52-Week High 17.4900
Fibonacci 61.8% 10.9845
Fibonacci 50% 8.9750
Fibonacci 38.2% 6.9655
Last Price 0.8601
52-Week Low 0.4600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar